Signifor
These highlights do not include all the information needed to use SIGNIFOR safely and effectively. See full prescribing information for SIGNIFOR. SIGNIFOR (pasireotide) injection, for subcutaneous use Initial U.S. Approval: 2012
a09a25fc-a5a3-0c82-e053-2995a90a5d74
HUMAN PRESCRIPTION DRUG LABEL
Aug 3, 2023
Recordati Rare Diseases, Inc.
DUNS: 181699406
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
pasireotide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
pasireotide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
pasireotide
Product Details
FDA regulatory identification and product classification information